Favipiravir (Avigan) for COVID-19

Date of publication: April 8, 2020


  • To search and synthesize information on the market approval of Favipiravir in different settings
  • To search for existing COVID-19 treatment guidelines (TGs) or clinical practice guidelines (CPG) recommending its use, as well as existing evidence on its clinical efficacy, safety and cost-effectiveness